Phase I single- and multiple-ascending dose trial of intravenous ceftolozane in volunteers

Trial Profile

Phase I single- and multiple-ascending dose trial of intravenous ceftolozane in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Mar 2009

At a glance

  • Drugs Ceftolozane (Primary)
  • Indications Bacterial infections; Cystic fibrosis-associated respiratory tract infections; Urinary tract infections
  • Focus Adverse reactions
  • Sponsors Calixa Therapeutics
  • Most Recent Events

    • 31 Mar 2009 New trial record.
    • 24 Mar 2009 Results reported in a Calixa Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top